Risk factors for kala-azar in Bangladesh

被引:136
作者
Bern, C
Hightower, AW
Chowdhury, R
Ali, M
Amann, J
Wagatsuma, Y
Haque, R
Kurkjian, K
Vaz, LE
Begum, M
Akter, T
Cetre-Sossah, CB
Ahluwalia, IB
Dotson, E
Secor, WE
Breiman, RF
Maguire, JH
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA USA
[2] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh
关键词
D O I
10.3201/eid1105.040718
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Since 1990, South Asia has experienced a resurgence of kala-azar (visceral leishmaniasis). To determine risk factors for kala-azar, we performed cross-sectional surveys over a 3-year period in a Bangladeshi community. By history, active case detection, and serologic screening, 155 of 2,356 residents had kala-azar with onset from 2000 to 2003. Risk was highest for persons 3-45 years of age, and no significant difference by sex was seen. In age-adjusted multivariable models, 3 factors were identified: proximity to a previous kala-azar patient (odds ratio [OR] 25.4, 95% confidence interval [CI] 15-44 within household; OR 3.2 95% CI 1.7-6.1 within 50 m), bed net use in summer (OR 0.7, 95% CI 0.53-0.93), and cattle per 1,000 m(2) (OR 0.8, 95% CI 0.70-0.94]). No difference was seen by income, education, or occupation; land ownership or other assets; housing materials and condition; or keeping goats or chickens inside bedrooms. Our data confirm strong clustering and suggest that insecticide-treated nets could be effective in preventing kala-azar.
引用
收藏
页码:655 / 662
页数:8
相关论文
共 22 条
[11]   Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda [J].
Guerin, PJ ;
Olliaro, P ;
Sundar, S ;
Boelaert, M ;
Croft, SL ;
Desjeux, P ;
Wasunna, MK ;
Bryceson, ADM .
LANCET INFECTIOUS DISEASES, 2002, 2 (08) :494-501
[12]   A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy [J].
Houghton, RL ;
Petrescu, M ;
Benson, DR ;
Skeiky, YAW ;
Scalone, A ;
Badaró, RT ;
Reed, SG ;
Gradoni, L .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) :1339-1344
[13]   Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection [J].
Karplus, TM ;
Jeronimo, SMB ;
Chang, H ;
Helms, BK ;
Burns, TL ;
Murray, JC ;
Mitchell, AA ;
Pugh, EW ;
Braz, RFS ;
Bezerra, FL ;
Wilson, ME .
INFECTION AND IMMUNITY, 2002, 70 (12) :6919-6925
[14]  
Kumar R, 1999, B WORLD HEALTH ORGAN, V77, P371
[15]  
MUKHOPADHYAY AK, 1987, INDIAN J MED RES, V86, P475
[16]  
MURRAY JCL, 1996, GLOBAL HLTH STAT COM, V2
[17]  
PEARSON RD, 1999, TROPICAL INFECT DIS, P797
[18]  
REES PH, 1987, LEISHMANIASES BIOL M, V2, P584
[19]   A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan [J].
Reyburn, H ;
Ashford, R ;
Mohsen, M ;
Hewitt, S ;
Rowland, M .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2000, 94 (04) :361-366
[20]   Noninvasive management of Indian visceral leishmaniasis: Clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit [J].
Sundar, S ;
Sahu, M ;
Mehta, H ;
Gupta, A ;
Kohli, U ;
Rai, M ;
Berman, JD ;
Murray, HW .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (05) :581-586